Difference between revisions of "Brain metastasis"

Jump to navigation Jump to search
46 bytes added ,  05:34, 29 October 2014
Line 76: Line 76:
**[[Clear cell renal cell carcinoma]]: PAX8 +ve, CK7 -ve, CK20 -ve, vimentin +ve, CD10 +ve.
**[[Clear cell renal cell carcinoma]]: PAX8 +ve, CK7 -ve, CK20 -ve, vimentin +ve, CD10 +ve.
*Melanoma: S-100 +ve, HMB-45 +ve, Melan A +ve.
*Melanoma: S-100 +ve, HMB-45 +ve, Melan A +ve.
*GFAP -ve.<ref name=pmid23717796 >{{Cite journal  | last1 = Pekmezci | first1 = M. | last2 = Perry | first2 = A. | title = Neuropathology of brain metastases. | journal = Surg Neurol Int | volume = 4 | issue = Suppl 4 | pages = S245-55 | month =  | year = 2013 | doi = 10.4103/2152-7806.111302 | PMID = 23717796 }}</ref>


Others:<ref name=pmid23717796 >{{Cite journal  | last1 = Pekmezci | first1 = M. | last2 = Perry | first2 = A. | title = Neuropathology of brain metastases. | journal = Surg Neurol Int | volume = 4 | issue = Suppl 4 | pages = S245-55 | month =  | year = 2013 | doi = 10.4103/2152-7806.111302 | PMID = 23717796 }}</ref>
Other glial markers (suggest primary):<ref name=pmid23717796/>
*GFAP -ve.
*OLIG2, SOX2.
*OLIG2 -ve.
*SOX2 -ve.


==See also==
==See also==
48,466

edits

Navigation menu